Formation of biocompatible MgO/cellulose grafted hydrogel for efficient bactericidal and controlled release of doxorubicin.
Anti-Bacterial Agents
/ pharmacology
Antineoplastic Agents
/ pharmacology
Cellulose
/ chemistry
Delayed-Action Preparations
/ pharmacology
Doxorubicin
/ pharmacology
Hydrogels
/ chemistry
Magnesium Oxide
/ pharmacology
Molecular Docking Simulation
Nanocomposites
/ chemistry
Nanogels
Nanoparticles
/ chemistry
Prospective Studies
Reactive Oxygen Species
Cellulose nanocrystals (CNC)
Hydrogel
Poly (acrylic acid) (PAA)
Journal
International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578
Informations de publication
Date de publication:
01 Nov 2022
01 Nov 2022
Historique:
received:
19
06
2022
revised:
12
08
2022
accepted:
17
08
2022
pubmed:
29
8
2022
medline:
15
10
2022
entrez:
28
8
2022
Statut:
ppublish
Résumé
In this study, MgO-doped CNC-g-PAA hydrogel was synthesized by grafting poly (acrylic acid) (PAA) onto cellulose nanocrystals (CNC) and then doped Magnesium oxide (MgO) using pH 7.0 and 12.0 to obtain an efficient nanocomposite hydrogel for antibacterial and anti-cancer activities. The synthesized nanocomposite hydrogels were evaluated by detailed characterization and confirmed the formation of a well-interconnected porous structure. MgO/CNC-g-PAA (pH = 12.0) exhibited improved bactericidal tendencies towards gram-negative and gram-positive bacteria, which was further investigated by in-silico molecular docking analyses and also examined the reactive oxygen species production by photocatalysis and free radical-scavenging assay. After this, Doxorubicin (DOX), a model anticancer drug, was successfully loaded into nanocomposites (∼79 %) by electrostatic interaction and confirmed pH-triggered based release, which was over 53.7 % in 24 h. Finally, in vitro cytotoxicity-based analysis confirmed the improved antitumor efficacy of nanocomposite hydrogels. These findings revealed that MgO/CNC-g-PAA hydrogels might be prospective carriers for controlled drug delivery.
Identifiants
pubmed: 36030978
pii: S0141-8130(22)01845-1
doi: 10.1016/j.ijbiomac.2022.08.142
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Antineoplastic Agents
0
Delayed-Action Preparations
0
Hydrogels
0
Nanogels
0
Reactive Oxygen Species
0
Magnesium Oxide
3A3U0GI71G
Doxorubicin
80168379AG
Cellulose
9004-34-6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1277-1286Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare no conflict of interest.